A Chinese Patent Medicine JiaYanKangTai Alleviates Inflammatory Lesions of Experimental Autoimmune Thyroiditis by Regulating Interleukin-17 Signaling
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2021.794568
Abstract: Objective This study was aimed to investigate the effects of JiaYanKangTai (JYKT) on regulating interleukin-17 (IL-17) signaling in rats with autoimmune thyroiditis. Methods Lewis rats were administrated with JYKT for eight weeks after a seven-week… read more here.
Keywords: jykt; interleukin signaling; autoimmune thyroiditis; regulating interleukin ... See more keywords